Abstract

The use of gene therapeutics, including short interfering RNA (siRNA), is limited by the lack of efficient delivery systems. An appealing approach to deliver gene therapeutics involves noncovalent complexation with cell penetrating peptides (CPPs) which are able to penetrate the cell membranes of mammals. Although a number of CPPs have been discovered, our understanding of their complexation and translocation of siRNA is as yet insufficient. Here, we report on computational studies comparing the binding affinities of CPPs with siRNA, considering a variety of CPPs. Specifically, seventeen CPPs from three different categories, cationic, amphipathic, and hydrophobic CPPs, were studied. Molecular mechanics were used to minimize structures, while molecular docking calculations were used to predict the orientation and favorability of sequentially binding multiple peptides to siRNA. Binding scores from docking calculations were highest for amphipathic peptides over cationic and hydrophobic peptides. Results indicate that initial complexation of peptides will likely occur along the major groove of the siRNA, driven by electrostatic interactions. Subsequent binding of CPPs is likely to occur in the minor groove and later on bind randomly, to siRNA or previously bound CPPs, through hydrophobic interactions. However, hydrophobic CPPs do not show this binding pattern. Ultimately binding yields a positively charged nanoparticle capable of noninvasive cellular import of therapeutic molecules.

Highlights

  • Therapeutics have shown a vast diversification from small molecule drugs

  • A general cause of lower cellular uptake of gene therapeutics is the poor penetration through the cell membrane, which is efficient in regulating the internalization of foreign substances

  • This paper focuses on cell penetrating peptides (CPPs) with respect to their delivery of short interfering RNA (siRNA) to cells through the use of computer modeling and simulation

Read more

Summary

Introduction

Therapeutics have shown a vast diversification from small molecule drugs. Peptide and nucleic acid based therapeutics are among these alternatives and have been developed tremendously, to the point of clinical trials [1,2,3]. Nitrogen base pairs which are exposed grooves of the RNA can become involved in sequence specific H bonds [28, 30] It follows that the conformation of dsRNA influences the binding of peptides due to the presence of 2󸀠-OH groups in RNA; it naturally exists mostly in the thermodynamically stable A-form [31]. Further aggregation of these complexes forms dense nanoparticles, with a size of 102 nm that may be internalized via endosomes [12, 32, 33] This formation of a positively charged nanoparticle is important for translocation into the cell membrane and delivering the therapeutics. To achieve a complete understanding about the binding of CPPs to siRNA, we performed docking calculations for 17 different peptides from all the structural classes. To generalize the findings of the study, siRNA downregulating Human Papillomavirus (type 16) E6 oncoprotein, si16E6, was used for comparison

Methodology
Results and Discussion
CADY MPG
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call